Imiquimod
Imiquimod is an approved active ingredient.
Chemical compound
What it is used for
- Basal-cell carcinoma of the skin
- Actinic keratosis
- Anogenital venereal wart
- Skin cancer
- Common wart
- Viral infectious disease
- Keratosis
Imiquimod Cream, 3.75% is indicated for the topical treatment of clinically typical, visible, or palpable actinic keratoses (AK) of the face or balding scalp in immunocompetent adults.
Imiquimod cream is indicated for the topical treatment of: External genital and perianal warts (condylomata acuminata) in adults. Small superficial basal cell carcinomas (sBCCs) in adults.
How it works
- Toll-like receptor 7 agonist
Common side effects
The following clinically significant adverse reactions are described elsewhere in the labeling: Local Skin Reactions Systemic Reactions Most common adverse reactions (≥4%) are local skin reactions (erythema, scabbing/crusting, flaking/scaling/dryness, edema, erosion/ulceration, exudate), headache, application site…
Pregnancy and breastfeeding
Available data from case reports and case series have not established a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes when imiquimod is used during pregnancy.
Brand names
United States
Aldara · Zyclara
European Union
Aldara · Zyclara
Canada
Aldara P · Taro-Imiquimod · Taro-Imiquimod Pump · Vyloma · Zyclara
Other trade names
Zartra
Approval status
- US Food and Drug Administration
- prescription · since 1997
- European Medicines Agency
- authorised · since 1998
- Health Canada
- prescription · marketed
- First approval anywhere
- 1997
Codes
- ATC
- D06BB10
- RxNorm CUI
- 59943
- ChEMBL
- CHEMBL1282
- PubChem CID
- 57469
- UNII
- P1QW714R7M
- Wikidata
- Q423417
Frequently asked questions
What is Imiquimod used for?
Imiquimod is used for: Basal-cell carcinoma of the skin, Actinic keratosis, Anogenital venereal wart, Skin cancer, Common wart, Viral infectious disease, and Keratosis.
What are the brand names of Imiquimod?
Brand names of Imiquimod include Aldara, Zyclara, Aldara P, Taro-Imiquimod, Taro-Imiquimod Pump, Vyloma, and Zartra.
Medicines in the same class
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- European Medicines Agency (reuse with acknowledgement)
- Health Canada Drug Product Database (Open Government Licence – Canada)